COMMUNIQUÉS West-GlobeNewswire

EDAP Announces Significant Presence of Focal One® at the Upcoming 120th American Urological Association (AUA) Annual Meeting
22/04/2025
Activities to include expert-led demonstrations, semi-live Focal One procedures and hands-on simulations Final results of randomized clinical trial (FARP Study) comparing ultrasound-based focal ablation versus radical [...]
Aclaris Therapeutics Secures U.S. Food and Drug Administration IND Clearance for ATI-052, Enabling Advancement of its Novel Bispecific Anti-TSLP/IL-4R Investigational Antibody
22/04/2025
- Initiation of Upcoming Phase 1a/1b Clinical Trial Expected in the Second Quarter of 2025 - WAYNE, Pa, April 22, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical [...]
Arch Biopartners Announces Toronto General Hospital Ethics Board Approval to Join the Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury (CS-AKI)
22/04/2025
TORONTO, April 22, 2025 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. , (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that the University Health Network (UHN) Research Ethics Board has [...]
BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025
22/04/2025
MAINZ, Germany, April 22, 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the first quarter 2025 on Monday, May 5, 2025. Additionally, the Company [...]
R3 Vascular Announces First Patient Treated in ELITE-BTK Pivotal Trial for Below-the-Knee PAD Using MAGNITUDE® Drug Eluting Bioresorbable Scaffold
22/04/2025
MOUNTAIN VIEW, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial [...]
AscellaHealth Demonstrates Leadership in Realizing the Full Potential of Novel Therapies and Medicinal Products at Advanced Therapies Integrates North 2025
22/04/2025
DUBLIN and BERWYN, Pa., April 22, 2025 (GLOBE NEWSWIRE) -- AscellaHealth , a global partner delivering customisable solutions to support the specialty pharmaceutical industry, proudly announces its participation in [...]
Regeneron Announces New Investment in Manufacturing of its Industry-Leading Biologic Medicines
22/04/2025
New manufacturing and supply agreement with FUJIFILM Diosynth Biotechnologies in North Carolina will enable additional production of Regeneron’s biologic medicines and support high-paying jobs in the region Regeneron’s [...]
PrimeBiome Reviews: “Gut–Skin Miracle” or Just Hype? Expert Insights
22/04/2025
St. Petersburg, Florida, April 22, 2025 (GLOBE NEWSWIRE) -- With over 19,000 customer reviews and rising buzz across wellness communities, Prime Biome is being hailed as a “gut–skin miracle”—but does it actually live up [...]
Prime Biome Reviews 2025: Updated Comprehensive Guide to the Revolutionary Gut & Skin Health Supplement!
22/04/2025
A 360° Look at Ingredients, Expert Insights, Real Results & User Feedback St. Petersburg, Florida, April 22, 2025 (GLOBE NEWSWIRE) -- Explore how PrimeBiome is transforming gut and skin health in 2025. This detailed [...]
Lipella Reports Positive Phase 2a Results from Second LP-310 Cohort in Oral Lichen Planus; Final Data Expected Q2 2025
22/04/2025
Second Cohort Results Highlight Efficacy Across All Key Measures and Reinforce Safety of Twice-Daily Oral Rinse Phase 2a Study Now Fully Enrolled Across All Three Dose Cohorts Advancing Toward Phase 2b IND Submission [...]
CARBOGEN AMCIS Shanghai Site Awarded Drug Manufacturing License from Chinese NMPA
22/04/2025
BUBENDORF, Switzerland, April 22, 2025 (GLOBE NEWSWIRE) -- CARBOGEN AMCIS, a Switzerland-based pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company is pleased to announce [...]
Alpha Bites Gummies Reviews (WARNING) Is It Safe for Men’s Health? Understanding Its Natural Ingredients And Benefits!
22/04/2025
ORLANDO, Fla., April 22, 2025 (GLOBE NEWSWIRE) -- Any man looking for an easier and more effective way to increase their overall health and vitality must have come across several dietary supplements with different [...]
Telix Reports US$186M Q1 Revenue, Up 62% YOY
22/04/2025
MELBOURNE, Australia and INDIANAPOLIS, April 22, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today provides an update on its commercial and operational performance [...]
Sirona Biochem Secures Strategic Investment Agreements and New Joint Venture with Promura GmbH
22/04/2025
VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”) , a biotechnology company specializing cosmetic ingredients and new drug discoveries, [...]
Best Supplements for Menopause Weight Gain and Belly Fat 2025 - Top Supplement for Menopausal Weight Loss By YourBiology
22/04/2025
GLASGOW, United Kingdom, April 22, 2025 (GLOBE NEWSWIRE) -- Menopause often brings challenges like stubborn belly fat, slowed metabolism, and hormonal weight gain, leaving many women frustrated. The good news? With the [...]
Mitolyn Reviews: Ingredients, Benefits, Pros and Cons! Honest Analysis Inside!
22/04/2025
Albany, New York, April 22, 2025 (GLOBE NEWSWIRE) -- If you're struggling with stubborn weight, low energy, or slow metabolism, Mitolyn might be the breakthrough you've been waiting for. Touted as a cutting-edge [...]
Mitolyn Reviews (Investigative Warning 2025): A Comprehensive Review of the Revolutionary Mitochondrial and Cellular Health Supplement
22/04/2025
The Mitolyn Effect—Real-Life Transformations Backed by Cutting-Edge Science New York City, April 22, 2025 (GLOBE NEWSWIRE) -- The recent energy drops together with slowing metabolic processes and cognitive decline [...]
Invitation to Orion’s Capital Markets Day on 22 May 2025
22/04/2025
ORION CORPORATION INVESTOR NEWS 22 APRIL 2025 at 9.00 EEST Invitation to Orion’s Capital Markets Day on 22 May 2025 Orion invites analysts, institutional investors, bankers and media representatives to its Capital [...]
Zelluna Reaches Major Milestone with Manufacturing Process Established in Preparation for Clinical Entry of ZI-MA4-1, its Novel TCR-NK Therapy Targeting Solid Tumours
22/04/2025
Oslo, Norway, 22 April 2025 – Zelluna (OSE: ZLNA), a company pioneering allogeneic ‘off the shelf’ T Cell Receptor based Natural Killer (TCR-NK) cells for the treatment of cancer, has successfully developed, scaled and [...]

Pages